India · Delayed Price · Currency is INR Medico Remedies Statistics
Total Valuation
Medico Remedies has a market cap or net worth of INR 3.95 billion. The enterprise value is 4.06 billion.
| Market Cap | 3.95B |
| Enterprise Value | 4.06B |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medico Remedies has 82.98 million shares outstanding. The number of shares has increased by 0.68% in one year.
| Current Share Class | 82.98M |
| Shares Outstanding | 82.98M |
| Shares Change (YoY) | +0.68% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 74.96% |
| Owned by Institutions (%) | 1.20% |
| Float | 20.08M |
Valuation Ratios
The trailing PE ratio is 34.92.
| PE Ratio | 34.92 |
| Forward PE | n/a |
| PS Ratio | 2.30 |
| PB Ratio | 5.91 |
| P/TBV Ratio | 5.92 |
| P/FCF Ratio | 480.64 |
| P/OCF Ratio | 94.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.60, with an EV/FCF ratio of 493.72.
| EV / Earnings | 35.80 |
| EV / Sales | 2.37 |
| EV / EBITDA | 26.60 |
| EV / EBIT | 33.05 |
| EV / FCF | 493.72 |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.62 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.82 |
| Debt / FCF | 15.23 |
| Interest Coverage | 12.51 |
Financial Efficiency
Return on equity (ROE) is 18.55% and return on invested capital (ROIC) is 12.13%.
| Return on Equity (ROE) | 18.55% |
| Return on Assets (ROA) | 6.50% |
| Return on Invested Capital (ROIC) | 12.13% |
| Return on Capital Employed (ROCE) | 18.36% |
| Weighted Average Cost of Capital (WACC) | 5.21% |
| Revenue Per Employee | 8.06M |
| Profits Per Employee | 532,709 |
| Employee Count | 213 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 4.30 |
Taxes
In the past 12 months, Medico Remedies has paid 37.58 million in taxes.
| Income Tax | 37.58M |
| Effective Tax Rate | 24.88% |
Stock Price Statistics
The stock price has decreased by -31.09% in the last 52 weeks. The beta is 0.17, so Medico Remedies's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -31.09% |
| 50-Day Moving Average | 49.73 |
| 200-Day Moving Average | 47.46 |
| Relative Strength Index (RSI) | 45.10 |
| Average Volume (20 Days) | 14,506 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medico Remedies had revenue of INR 1.72 billion and earned 113.47 million in profits. Earnings per share was 1.36.
| Revenue | 1.72B |
| Gross Profit | 459.61M |
| Operating Income | 122.90M |
| Pretax Income | 151.04M |
| Net Income | 113.47M |
| EBITDA | 148.53M |
| EBIT | 122.90M |
| Earnings Per Share (EPS) | 1.36 |
Balance Sheet
The company has 17.64 million in cash and 125.27 million in debt, with a net cash position of -107.64 million or -1.30 per share.
| Cash & Cash Equivalents | 17.64M |
| Total Debt | 125.27M |
| Net Cash | -107.64M |
| Net Cash Per Share | -1.30 |
| Equity (Book Value) | 668.58M |
| Book Value Per Share | 8.07 |
| Working Capital | 433.92M |
Cash Flow
In the last 12 months, operating cash flow was 42.01 million and capital expenditures -33.78 million, giving a free cash flow of 8.23 million.
| Operating Cash Flow | 42.01M |
| Capital Expenditures | -33.78M |
| Free Cash Flow | 8.23M |
| FCF Per Share | 0.10 |
Margins
Gross margin is 26.77%, with operating and profit margins of 7.16% and 6.61%.
| Gross Margin | 26.77% |
| Operating Margin | 7.16% |
| Pretax Margin | 8.80% |
| Profit Margin | 6.61% |
| EBITDA Margin | 8.65% |
| EBIT Margin | 7.16% |
| FCF Margin | 0.48% |
Dividends & Yields
Medico Remedies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.68% |
| Shareholder Yield | -0.68% |
| Earnings Yield | 2.87% |
| FCF Yield | 0.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 16, 2023. It was a forward split with a ratio of 5.
| Last Split Date | Mar 16, 2023 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |